We're looking forward to attending #medSCAI2024 today! Thank you, Cellarity, for featuring our NRF2 program as part of the third annual symposium on medicines, single cell technology, and AI. Join us in watching Joey Azofeifa's presentation: “Massively high throughput transcriptomics discovers a molecular glue degrading NRF2 in lung cancer” at 12:45 ET! https://lnkd.in/ddxuVCt5
Attend #medSCAI24—our third annual symposium on medicines, single cell technology and #AI! Join esteemed industry leaders for two sessions focused on AI and #MachineLearning-powered #DrugDiscovery. Hear from Arpeggio Biosciences CEO Joey Azofeifa and professors Paul Blainey, from MIT Department of Biological Engineering, and Cole Trapnell, from University of Washington’s Department of Genome Sciences in ‘Session 1: From Data to New Biology.’ Caroline Gubser Keller, Global Head of Data Science at Novartis BioMedical Research, will lead ‘Session 2: From Biology and Computation to Translation’ with a discussion about innovative applications of AI and ML. Register Today ➡️ https://bit.ly/3yOdJEL